WSJ.com: Health

Health
  1. Lawmakers To Vote on FDA Clout
    The Senate could vote as soon as next week on whether to give the Food and Drug Administration broader regulatory authority, including new powers to prevent prescription-drug shortages.
  2. Red Tape Hobbles a Harvest of Life-Saving Rice
    Matt Ridlley on the lifesaving role of micronutrients and how a dispute over rice is depriving the poor.
  3. India's Drug Proposals Spark Debate
    India's government is facing stiff resistance from foreign and local pharmaceutical companies over its plan to severely limit prices for drugs.
  4. Agonizing Choices for Heart Patients
    Some heart patients are making the decision to have their troubled Riata defibrillator leads removed even when the devices are still working properly.
  5. FDA Approves Generic Versions of Plavix
    The U.S. Food and Drug Administration on Thursday approved generic versions of blood-thinning drug Plavix.
  6. Human Genome Adopts Poison Pill
    Human Genome Sciences adopted a shareholder rights plan with a 15% trigger in the wake of Glaxo's $2.6 billion hostile takeover bid for the biotech firm.
  7. Drug Trial Boosts Hope for Tailored Treatment
    Pfizer's drug Xalkori for adult lung cancer is showing promise against childhood cancers, illustrating how personalized medicine is emerging as a weapon against pediatric malignancies.
  8. Bid to Coax States on Health Exchanges
    The Obama administration on Wednesday made a fresh bid to coax reluctant governors to work with the federal government to help enact the health-overhaul law.
  9. Zytiga Can Nix Some Prostate Tumors
    A study looking at small group of men with prostate cancer showed the use of Johnson & Johnson's Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated for six months before surgery.
  10. Stroke Victims Move Robot Arm With Thoughts
    Two paralyzed patients used their thoughts to steer a robotic arm and grasp physical objects, a notable advance in the quest to restore some function to people with limb paralysis.
  11. Federal Probe of Medtronic Ends
    A federal probe into Medtronic's marketing of a bone-graft product, Infuse, is over, the company said.
  12. New Bid to Prevent Alzheimer's Early
    An Alzheimer's drug will be tested for the first time in a large-scale trial on at-risk people who don't yet show signs of memory loss.
  13. Lead-Poisoning Threshold for Kids Revised
    U.S. health officials halved the minimum threshold for lead poisoning in children younger than 6.
  14. Crib Tents Recalled
    The Consumer Product Safety Commission said five retailers are voluntarily recalling crib tents and play-yard tents made by the now-defunct Tots in Mind, due to strangulation and entrapment hazards.
  15. FDA Panel Backs HIV Home Test
    An FDA advisory panel asked the agency to let an HIV test be sold at stores so consumers can get tested for the AIDS virus at home.

Additional information